Fol. Biol. 2021, 67, 1-9

https://doi.org/10.14712/fb2021067010001

Questioning How to Define the “Ultra-High-Risk” Subgroup of Neuroblastoma Patients

A. B. Demir1,2, Safiye Aktas2, Z. Altun2, P. Ercetin2, T. C. Aktas2, N. Olgun3

1Department of Basic Medical Sciences, Faculty of Medicine, Izmir University of Economics, Izmir, Turkey
2Department of Basic Oncology, Institute of Oncology, Dokuz Eylul University, Izmir, Turkey
3Department of Clinical Oncology, Institute of Oncology, Dokuz Eylul University, Izmir, Turkey

Received April 2020
Accepted November 2020

Crossref Cited-by Linking

  • Wang Haoru, Chen Xin, Li Ting, Xie Mingye, Qin Jinjie, Zhang Li, Ding Hao, He Ling: Identification of an Ultra-High-Risk Subgroup of Neuroblastoma Patients within the High-Risk Cohort Using a Computed Tomography-Based Radiomics Approach. Academic Radiology 2024, 31, 1655. <https://doi.org/10.1016/j.acra.2023.08.022>
  • Bruinsma Rixt S., Fiocco Marta F., de Leng Wendy W. J., Kester Lennart A., Langenberg Karin P. S., Tytgat Godelieve A. M., van Noesel Max M., Wijnen Marc H. W. A., van der Steeg Alida F. W., de Krijger Ronald R.: mRNA Expression Level of ALK in Neuroblastoma Is Associated with Histological Subtype, ALK Mutations and ALK Immunohistochemical Protein Expression. JMP 2024, 5, 304. <https://doi.org/10.3390/jmp5030022>
  • Aktaş Tekincan Çağrı, Kızmazoğlu Deniz, Aktaş Safiye, Gökbayrak Özde Elif, Serinan Efe, Erol Aylin, Altun Zekiye, Yuan Hongling, Olgun Hatice Nur: Identification of ALK Mutation in Neuroblastoma on the Point of Molecular Heterogeneity. Technol Cancer Res Treat 2023, 22. <https://doi.org/10.1177/15330338231211138>
  • DEMİR Ayse Banu, ALTUN Zekiye, AKTAŞ Safiye, OLGUN Nur: More Abundant Superoxide Dismutase2 Protein Levels in Blood May Act as a Prognostic Marker for High-Risk Neuroblastoma Patients. Journal of Basic and Clinical Health Sciences 2023, 7, 196. <https://doi.org/10.30621/jbachs.1071115>
  • Aktaş Tekincan Çağrı, Aktaş Safiye, Serinan Efe Özgür, Erçetin Pınar, Aydın Melek, Gökbayrak Özde Elif, Erol Aylin, Altun Zekiye, Olgun Nur: Molecular Heterogeneity in Neuroblastoma and Its Clinical Significance. buchd 2023, 13, 123. <https://doi.org/10.4274/buchd.galenos.2023.14238>
Crossref Cited-by Linking logo